| Loss of Pfizer (BNT162b2) vaccine-induced antibody responses against the SARS-CoV-2 Omicron variant in adolescents and adults SL Gupta, G Mantus, KE Manning, M Ellis, M Patel, CR Ciric, A Lu, ... Journal of virology 96 (17), e00582-22, 2022 | 16 | 2022 |
| Novel ablative laser mediated transdermal immunization for microparticulate measles vaccine D Joshi, RP Gala, MN Uddin, MJ D'Souza International journal of pharmaceutics 606, 120882, 2021 | 16 | 2021 |
| Evaluation of microparticulate (S)-4, 5-dihydroxy-2, 3-pentanedione (DPD) as a potential vaccine adjuvant D Joshi, C Chbib, MN Uddin, MJ D’Souza The AAPS Journal 23 (4), 84, 2021 | 15 | 2021 |
| Subunit microparticulate vaccine delivery using microneedles trigger significant SARS-spike-specific humoral and cellular responses in a preclinical murine model S Patil, S Vijayanand, D Joshi, I Menon, KB Gomes, A Kale, P Bagwe, ... International Journal of Pharmaceutics 632, 122583, 2023 | 10 | 2023 |
| Novel microparticulate Zika vaccine induces a significant immune response in a preclinical murine model after intramuscular administration A Kale, D Joshi, I Menon, P Bagwe, S Patil, S Vijayanand, KB Gomes, ... International Journal of Pharmaceutics 624, 121975, 2022 | 10 | 2022 |
| Prior SARS‐CoV‐2 infection and COVID‐19 vaccine effectiveness against outpatient illness during widespread circulation of SARS‐CoV‐2 Omicron variant, US Flu VE network SY Tartof, F Xie, R Yadav, KJ Wernli, ET Martin, EA Belongia, M Gaglani, ... Influenza and Other Respiratory Viruses 17 (5), e13143, 2023 | 9 | 2023 |
| Microneedle Delivery of an Adjuvanted Microparticulate Vaccine Induces High Antibody Levels in Mice Vaccinated against Coronavirus S Vijayanand, S Patil, D Joshi, I Menon, K Braz Gomes, A Kale, P Bagwe, ... Vaccines 10 (9), 1491, 2022 | 8 | 2022 |
| Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birth F Wimmers, AR Burrell, Y Feng, H Zheng, PS Arunachalam, M Hu, ... Cell 186 (21), 4632-4651. e23, 2023 | 5 | 2023 |
| Formulation and characterization of microcapsules encapsulating PC12 cells as a prospective treatment approach for Parkinson’s disease DJ Joshi, NM Chitre, A Bansal, KS Murnane, MJ D’Souza AAPS PharmSciTech 22 (4), 149, 2021 | 5 | 2021 |
| Oral vaccine delivery: The coming age of particulate vaccines to elicit mucosal immunity RP Gala, L Bajaj, A Bansal, KB Gomes, D Joshi, I Menon, RU Zaman, ... Mucosal Delivery of Drugs and Biologics in Nanoparticles, 155-175, 2020 | 3 | 2020 |
| Infants and young children generate more durable antibody responses to SARS-CoV-2 infection than adults D Joshi, LE Nyhoff, VI Zarnitsyna, A Moreno, K Manning, S Linderman, ... Iscience 26 (10), 2023 | 2 | 2023 |
| The autoinducer N-octanoyl-L-homoserine lactone (C8-HSL) as a potential adjuvant in vaccine formulations SM Shah, D Joshi, C Chbib, MA Roni, MN Uddin Pharmaceuticals 16 (5), 713, 2023 | 2 | 2023 |
| Zika Vaccine Microparticles (MPs)-Loaded Dissolving Microneedles (MNs) Elicit a Significant Immune Response in a Pre-Clinical Murine Model A Kale, D Joshi, I Menon, P Bagwe, S Patil, S Vijayanand, K Braz Gomes, ... Vaccines 11 (3), 583, 2023 | 2 | 2023 |
| Technology Update: Laser Ablation Technology for Transdermal Immunization D Joshi, MN Uddin, MJ D’Souza, RP Gala J Vaccines Vaccin. S 15, 2021 | 2 | 2021 |
| Systems biological assessment of the temporal dynamics of immunity to a viral infection in the first weeks and months of life F Wimmers, AR Burrell, Y Feng, H Zheng, PS Arunachalam, M Hu, ... medRxiv, 2023 | 1 | 2023 |
| Anti-SARS-CoV-2 Antibody Levels Associated With COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu Vaccine Effectiveness Network, October 2021-June 2022 KM Sumner, R Yadav, EK Noble, R Sandford, D Joshi, SY Tartof, ... JOURNAL OF INFECTIOUS DISEASES, 2024 | | 2024 |
| Anti–SARS-CoV-2 Antibody Levels Associated With COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu Vaccine Effectiveness Network, October 2021–June 2022 KM Sumner, R Yadav, EK Noble, R Sandford, D Joshi, SY Tartof, ... The Journal of Infectious Diseases, jiae090, 2024 | | 2024 |
| Potential of DPD ((S)-4, 5-dihydroxy-2, 3-pentanedione) Analogs in Microparticulate Formulation as Vaccine Adjuvants D Joshi, S Shah, C Chbib, MN Uddin Pharmaceuticals 17 (2), 184, 2024 | | 2024 |
| Vaccine adjuvants and carriers S Sarthak, P Dedeepya, A Emmanuel, B Amit, J Devyani, P Smital, ... Advanced Vaccination Technologies for Infectious and Chronic Diseases, 13-36, 2024 | | 2024 |
| Antibody response to symptomatic infection with SARS-CoV-2 Omicron variant viruses, December 2021—June 2022 R Sandford, R Yadav, EK Noble, K Sumner, D Joshi, SY Tartof, KJ Wernli, ... medRxiv, 2023 | | 2023 |
Priyal BagweMercer UniversityVerified email at live.mercer.edu
